VYOME HOLDINGS, INC. Adjustments to Additional Paid in Capital, Other
VYOME HOLDINGS, INC. (HIND) reported Adjustments to Additional Paid in Capital, Other of -$16.42 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2026-08-12
- VYOME HOLDINGS, INC. adjustments to additional paid in capital, other for the quarter ending 2026-06-30 was -$16.42K.
- VYOME HOLDINGS, INC. adjustments to additional paid in capital, other for the quarter ending 2026-03-31 was -$20.29K.
- VYOME HOLDINGS, INC. adjustments to additional paid in capital, other for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. adjustments to additional paid in capital, other for the quarter ending 2021-09-30 was $1.53M, a 47.05% decline year-over-year.
- VYOME HOLDINGS, INC. adjustments to additional paid in capital, other for fiscal 2021 was $4.51M, a 54.54% decline from fiscal 2020.
- VYOME HOLDINGS, INC. adjustments to additional paid in capital, other for fiscal 2020 was $9.92M.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$16.42K 10-Q · filed 2026-08-12 | -$36.71K derived: sum of 2 quarters · filed 2026-08-12 | ||
| 2026-03-31 | -$20.29K 10-Q · filed 2026-08-12 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $1.53M derived: sum of 2 quarters · filed 2023-04-17 | $1.53M derived: sum of 3 quarters · filed 2023-04-17 | $4.51M 10-K · filed 2023-04-17 |
| 2021-09-30 | $1.53M 10-Q · filed 2022-11-14 | $1.53M derived: sum of 2 quarters · filed 2022-11-14 | $4.51M 10-Q · filed 2022-11-14 | $10.13M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | $2.97M 10-Q · filed 2022-08-19 | $8.60M derived: sum of 3 quarters · filed 2022-08-19 | $11.50M derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-03-31 | $2.97M 10-Q · filed 2022-05-23 | $8.60M derived: sum of 2 quarters · filed 2022-05-23 | $11.50M derived: sum of 3 quarters · filed 2022-05-23 | |
| 2020-12-31 | $5.63M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $8.52M derived: sum of 2 quarters · filed 2022-04-08 | $9.92M 10-K · filed 2022-04-08 | |
| 2020-09-30 | $2.90M 10-Q · filed 2021-11-12 | $4.29M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $1.39M 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |